Last reviewed · How we verify

NCT07017621: HUGSquali

Qualitative Study on the Experiences of Mothers 6 to 12 Months After Their Participation in the Mother-baby Groups of the HUGS Study

Recruiting now Last updated 12 June 2025
What this trial tests

trial in Postnatal Depression in 16 participants. Currently enrolling.

Timeline
4 February 2025
Primary endpoint
4 February 2026
4 February 2026

Quick facts

Lead sponsorUniversity Hospital, Toulouse
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment16
Start date4 February 2025
Primary completion4 February 2026
Estimated completion4 February 2026
Sites3 locations across France

Conditions studied

Sponsor

University Hospital, Toulouse

Who can join

Eligibility, any sex, with Postnatal Depression or Postpartum Depression (PPD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The HUGS-QUALI study is a qualitative investigation that explores the experiences of mothers who participated in HUGS mother-baby therapy groups. Conducted 6 to 12 months after the intervention, the study aims to understand how this culturally adapted therapy influences the bond between mothers and their infants and affects their daily lives. By collecting detailed personal stories through in-depth interviews, the study seeks to understand if the adapted HUGS program effectively support French mothers in improving their interactions with their babies, when facing postpartum depression.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Postnatal Depression

Currently open trials in the same condition.

Other University Hospital, Toulouse trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07017621.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing